LN TV explores more about the FDA and the opioid epidemic.
Healthcare
New Therapy May Offer Some Cancer Patients Hope
Researchers from the Second Affiliated Hospital are aiming to perform the CAR T-cell therapy on one hundred multiple myeloma patients next year to further investigate the treatment’s effectiveness.Â
Abuse-Resistant Opioids Cause FDA Debate
The FDA is fighting with pharmaceutical companies over so-called “abuse-resistant opioids.”
Medicare For All in CA Doesn’t Add Up
The left desperately wants universal health care, but they just cannot seem to figure out how to make it work.
An Innovative Approach to 21st Century Healthcare
The idea of linking healthcare coverage to cell phone contracts might seem foolish, or even a joke, but the world today is unlike any era in the past.
CBO Report Says The AHCA Will Raise Uninsured, Shrink Goverment
Make no mistake – there are some tough decisions to be made which could hurt certain people. Whatever your thoughts about the AHCA are, it does shrink the size of government by over $2 trillion dollars over a decade and will help to balance the budget.
Why Veteran Treatment Matters
President George Washington’s proclamation that a nation will be judged by how it treats its defenders—meaning its veterans – seems not only prescient but apropos in our current day and age.
Healthcare’s Future in the Senate
After being resuscitated by sheer willpower, the American Health Care Act of 2017 is breathing again. Thanks to what was undoubtedly a tremendous effort by President Trump, Speaker Ryan, and several others, the plan to repeal and replace Obamacare has passed the House and now heads to the Senate. Its future is uncertain – indeed, the only thing you can be sure of is that whatever comes out of the Senate will look different than what the House sent over.
The Freedom Caucus, Health Care and the US Senate
In what could certainly be considered a symbolic victory for President Donald Trump, the second incarnation of the American Healthcare Act (AHCA) squeaked through a vote in the House of Representatives Thursday afternoon. Without a single Democrat vote, the bill was passed 217-213, with twenty Republicans voting against it. Although it may well not get through the Senate in its current form, a rift within the majority party has been bridged and that – in itself – is a victory for congressional Republicans who have seen so very few victories, of late.